morgen und übermorgen wird interessant...
American Society of Hematology (ASH) 2016 Annual Meeting
The Selective Anti Leukemic Effect of BL-8040, a Peptidic CXCR4 Antagonist, Is Mediated By Induction of Leukemic Blast Mobilization, Differentiation and Apoptosis: Results of Correlative Studies from a Ph2a Trial in Acute Myeloid Leukemia
Sunday, December 4, 2016, 6:00 PM-8:00 PM
ash.confex.com/ash/2016/webprogram/Paper91117.html
The High Affinity CXCR4 Inhibitor, BL-8040, Induces Apoptosis of AML Blasts and Their Terminal Differentiation By Blocking AKT/ERK Survival Signals and Downregulating BCL-2, MCL-1 and Cyclin-D1 through Regulation of Mir-15a/16-1 Expression
Monday, December 5, 2016: 11:30 AM
ash.confex.com/ash/2016/webprogram/Paper90019.html